Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.7M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
+2.23M
-
Total reported value, excl. options
-
$799M
-
Value change
-
+$96.7M
-
Put/Call ratio
-
1.62
-
Number of buys
-
92
-
Number of sells
-
-29
-
Price
-
$42.44
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q3 2024
150 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q3 2024.
GeneDx Holdings Corp. - Common Stock (WGS) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 28.7M outstanding shares and own 65.52% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (3.51M shares), Corvex Management LP (2.47M shares), BlackRock, Inc. (1.07M shares), GOLDMAN SACHS GROUP INC (1.05M shares), ORACLE INVESTMENT MANAGEMENT INC (1.05M shares), VANGUARD GROUP INC (849K shares), MILLENNIUM MANAGEMENT LLC (574K shares), GAGNON SECURITIES LLC (542K shares), Driehaus Capital Management LLC (473K shares), and Blackstone Inc. (421K shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.